Lung Diseases, Obstructive: Clinical Trials

65 trials for Lung Diseases, Obstructive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

35 completed, 11 unknown, 6 terminated, 4 recruiting. 65 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 165Completed 35, Unknown 11, Terminated 6, Recruiting 4, Active not recruiting 3, Withdrawn 3, Enrolling by invitation 2, Not yet recruiting 1

Follow Lung Diseases, Obstructive: new trials by email Literature Review of Lung Diseases, Obstructive trials Research Report on Lung Diseases, Obstructive

Trials (filtered) newest first · largest first

All 65 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy
REGEND007 - Chronic Obstructive Pulmonary Disease (COPD)
Early Phase 1RecruitingRegend Therapeutics122026-03-192026-03-23
Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells
Airway Basal Stem Cells - Pediatric Bronchiolitis Obliterans
Early Phase 1RecruitingRegend Therapeutics122025-11-112026-01-14
Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2
Donor-derived Treg cell injection combined with interleukin 2 - cGVHD
Early Phase 1RecruitingShanghai General Hospital, Shanghai Jiao Tong University School of Medicine182025-06-142025-09-30
Effectiveness of 1st Rib Mobilization and Scalene Muscles Muscle Energy Technique Among Patients With Asthma
First Rib Mobilization + Respiratory Physiotherapy, Scalene Muscle Energy Technique (MET) + Respiratory Physiotherapy - Asthma
Early Phase 1Active not recruitingSuperior University472025-03-042025-06-25
Observation Study on the Efficacy of Yiqi Gubiao Pill in the Treatment of Chronic Obstructive Pulmonary Disease Secondary to Active Pulmonary Tuberculosis
Yiqi Gubiao pill, Yiqi Gubiao Pill placebo - Tuberculosis-related Obstructive Pulmonary Disease
Early Phase 1Not yet recruitingFourth Affiliated Hospital of Xinjiang Medical University742024-11-302024-11-06
Airway Bypass - Safety and Feasibility Study
Airway Bypass - Emphysema or COPD
Early Phase 1UnknownZoar Engelman102024-01-262024-02-08
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
Magnesium Sulfate within the first hour, No Magnesium sulfate within the first hour - Asthma in Children, Asthma Attack
Early Phase 1RecruitingUniversity of Oklahoma1002023-11-302024-12-06
Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children
The use of a combination of microelements and vitamins against the background of physiotherapy - Respiratory Diseases, Congenital Heart Defects
Early Phase 1Enrolling by invitationTashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan6002023-11-082026-09-03
The Bronchiolitis in Hospitalized Infants Study
Dexamethasone Oral - Bronchiolitis
Early Phase 1WithdrawnIDeA States Pediatric Clinical Trials Network2023-10-092023-09-14
Short Acting Agents Vs Long Acting in Frequent Excerbator COPD Patients
SABA SAMA ICS Vs LABA LAMA ICs - Copd
Early Phase 1UnknownAssiut University802023-02-202023-03-01
Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)
MitoQ, Placebo - Chronic Obstructive Pulmonary Disease
Early Phase 1TerminatedVirginia Commonwealth University42023-02-162025-02-27
Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects
NJOY e-cigarette - Chronic Obstructive Pulmonary Disease
Early Phase 1Active not recruitingMilton S. Hershey Medical Center302022-11-222025-10-27
Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis
3% normal saline, steroid(beclomethasone dipropionate 400 μg/day) and salbutamol with 0.9% normal saline - Acute Bronchiolitis
Early Phase 1CompletedMardan Medical Complex602022-11-152023-11-21
Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)
LAIV - COPD
Early Phase 1CompletedUniversity of North Carolina, Chapel Hill242022-10-032026-06-23
Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD
Neuromuscular Electrical Nerve Stimulation, Usual Physiotherapy treatment (Chest Physiotherapy and mobility) - Chronic Obstructive Pulmonary Disease Moderate, Chronic Obstructive Pulmonary Disease Severe
Early Phase 1UnknownRandall Debattista1402022-10-012022-09-14
Therapeutic Effects of Jing Si Herbal Tea for COPD
Jing Si herbal tea (JSHT), Placebo - Airway Disease
Early Phase 1UnknownTaipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation1202022-01-012024-09-05
A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence
Quality-of-Life Assessment, Questionnaire Administration, Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine - Chronic Obstructive Pulmonary Disease, Lung Non-Small Cell Carcinoma
Early Phase 1CompletedRoswell Park Cancer Institute202021-11-222026-03-17
The Effect of Inhaled Nitric Oxide on Deadspace in COPD
Nitric Oxide, Placebo - Chronic Obstructive Pulmonary Disease
Early Phase 1CompletedDr. Denis O'Donnell132021-09-012024-04-03
Effectiveness of a Mobile Health Intervention in Improving the Technique of Inhaled Medications Among Children With Asthma
BreatheSuite - Asthma, Asthma in Children
Early Phase 1CompletedMemorial University of Newfoundland302021-01-012022-04-08
Treatment of CRF With Syndrome Differentiation of TCM
Placebo, Traditional Chinese medicine prescription - Chronic Respiratory Failure
Early Phase 1UnknownHenan University of Traditional Chinese Medicine1202021-01-012021-01-06

Showing 20 of 65. Sign in to see all of them.

Narrower conditions

Pulmonary Disease, Chronic Obstructive (34)  ·  Asthma (25)  ·  Bronchiolitis Obliterans Syndrome (6)  ·  Bronchiolitis Obliterans (3)  ·  Bronchiolitis (2)  ·  Dyspnea (2)  ·  Emphysema (2)  ·  Hypertension, Pulmonary (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Interstitial (2)  ·  Lung Neoplasms (2)  ·  Smoking (2)  ·  Angina Pectoris (1)  ·  Asbestosis (1)  ·  Blister (1)

Broader conditions

Respiratory Tract Diseases (64)  ·  Lung Diseases (63)  ·  Bronchial Diseases (37)  ·  Pathological Conditions, Signs and Symptoms (37)  ·  Chronic Disease (35)  ·  Disease Attributes (35)  ·  Pathologic Processes (35)  ·  Immune System Diseases (31)  ·  Hypersensitivity, Immediate (25)  ·  Respiratory Hypersensitivity (25)  ·  Hypersensitivity (24)  ·  Bronchitis (11)  ·  Bronchiolitis (8)  ·  Infections (8)

Interventions

montelukast (4)  ·  Mannitol (2)  ·  Standard of Care (2)  ·  Albuterol (1)  ·  Antigens, Dermatophagoides (1)  ·  Azithromycin (1)  ·  Budesonide (1)  ·  CIMAvax EGF (1)  ·  Curcumin (1)  ·  Cycloserine (1)  ·  Dexamethasone (1)  ·  Dobutamine (1)  ·  FluMist (1)  ·  Fluticasone-Salmeterol Drug Combination (1)  ·  Gadolinium (1)

Sponsors

Roxane Laboratories (4)  ·  AstraZeneca (2)  ·  Hamilton Health Sciences Corporation (2)  ·  Janssen Research & Development, LLC (2)  ·  Regend Therapeutics (2)  ·  Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Virginia Commonwealth University (2)  ·  Assiut University (1)  ·  Bellerophon (1)  ·  Black Tie Medical, Inc. (1)  ·  Columbia University (1)  ·  Col·legi de Farmacèutics de la Província de Barcelona (1)  ·  Dr. Denis O'Donnell (1)  ·  Emily DiMango, MD (1)

Countries

United States (33)  ·  Canada (7)  ·  United Kingdom (7)  ·  China (6)  ·  Germany (3)  ·  Belgium (2)  ·  France (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Pakistan (2)  ·  Spain (2)  ·  Austria (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Georgia (1)

Top investigators

Alan K Copa, PharmD (4)  ·  Gail Gauvreau, PhD (2)  ·  Paul O'Byrne, MD (2)  ·  Ashika Ahmed, MD (1)  ·  Ashley Deschamp, MD,MS (1)  ·  Cecil Charles, PhD (1)  ·  Chou-Chin Lan, MD (1)  ·  Christine A Sorkness, Pharm.D. (1)  ·  David Halpin, MD (1)  ·  Denis E O'Donnell, MD (1)  ·  Diego Castillo, MD (1)  ·  Dr. Tonio Agius, Physiotherapist (1)  ·  Elizabeth Oelsner, MD, MPH (1)  ·  Emily DiMango, MD (1)

Results publications

PMID 12359244, PMID 21687919, PMID 26310525, PMID 27486204, PMID 27978840, PMID 31332045, PMID 32883677, PMID 35584850, PMID 35691614, PMID 35762891, PMID 36572534, PMID 37020840, PMID 38249987, PMID 38798038, PMID 40455920, PMID 41132532

NIH funding

P01HL158507 (1), R01HL064368 (1), R01HL122424 (1), R01HL135235 (1), R01HL150081 (1), R01HL152436 (1), R61AT009989 (1), UL1TR001412 (1)